An open-label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.

Ramacciotti, E.Araujo, G. R.Lastoria, S.Maffei, Francisco Humberto de Abreu [UNESP]Dietrich, F.2014-05-202014-05-202002-11-16Blood. Washington: Amer Soc Hematology, v. 100, n. 11, p. 503A-503A, 2002.0006-4971http://hdl.handle.net/11449/31915503A-503AengAn open-label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.ResumoWOS:000179184701961Acesso restrito